DeutschNewstral
Article
Forbes on 2021-10-28 02:42
Study Finds Fluvoxamine — A $4 Antidepressant — May Cut Covid Hospitalization Risk
Related news
- Common Antidepressant Likely Cuts Risk Of Covid Hospitalization, Study FindsForbes
- BAntidepressant drug fluvoxamine may help reduce COVID hospitalization, study suggestsbeaconjournal.com
Daily coffee drinkers cut risk of melanoma, study findsexaminer-enterprise.com
Antidepressant use during pregnancy may double autism risk, study findsThe Japan Times
Ivermectin doesn’t cut Covid-19 hospitalization risk, new study showsSan Jose Mercury News
Ivermectin doesn’t cut Covid hospitalization risk, study showsocregister.com- Delta Variant More Than Doubles Risk Of Covid Hospitalization, U.K. Study FindsForbes
A cheap antidepressant lowers the risk of Covid hospitalization, a large study finds.The New York Times
Pfizer antiviral pill reduced risk of COVID hospitalization, death by 89% in high-risk people, study showspressherald.com
Smoking strong pot daily raises psychosis risk, study findsartesianews.com
Diabetes doubles risk of dying from coronavirus, study findsSouth China Morning Post- COVID: Hospitalization risk doubles with Delta variant, study suggestsSan Jose Mercury News
Covid-19 hospitalization risk doubles with Delta variant, study suggestsCNN- Vaccines cut risk of ‘long COVID’ in half, major study findspressherald.com
Dementia risk cut by one fruit as study finds eating it could stave off diseaseThe Daily Record- Blood Thinners Could Cut Risk Of Covid-19 Death In Hospital, Study FindsForbes